Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography.
- 1 October 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 80 (4) , 863-872
- https://doi.org/10.1161/01.cir.80.4.863
Abstract
Experimental studies of animals have previously demonstrated the validity of [1-11C]acetate as a tracer of oxidative metabolism for use with positron emission tomography. The present study was undertaken to define in normal human volunteers the relation between myocardial clearance kinetics of [1-11C]acetate, and the rate-pressure product as an index of myocardial oxygen consumption. Twenty-two studies were performed of 12 volunteers. The rate-pressure product was increased with continuous supine bicycle exercise in six studies. Of the 16 resting studies, seven were performed in the fasted state and nine following an oral glucose load, to define possible effects of substrate availability on the tracer-tissue kinetics. Myocardial tissue time-activity curves were biexponential. Clearance of activity was homogeneous throughout the myocardium. The rate constants k1, obtained from biexponential fitting, and kmono, obtained by monoexponential fitting of the initial linear portion of the time-activity curves, correlated well with the rate-pressure product. Although the correlation coefficient was higher for k1 than for kmono (0.95 vs. 0.91), analysis on a sectorial basis showed less regional variability in kmono. This suggests that kmono, which is more practical than k1 because it requires shorter acquisition times, may be more clinically and experimentally useful for detection of myocardial segments with abnormal oxygen consumption. Overall, changes in myocardial substrate supply were without significant effect on the relation between the rate constants (k1 and kmono) and the rate-pressure product, although a small decrease in kmono/rate-pressure product was observed following oral glucose by paired analysis in four subjects. It is concluded that [1-11C]acetate can be used for the noninvasive measurement of myocardial oxygen consumption in humans with positron emission tomography, and, thus, has clinical and experimental potential as a tool for the understanding and diagnosis of myocardial disease.This publication has 32 references indexed in Scilit:
- Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunctionAmerican Heart Journal, 1986
- Retention and clearance of C-11 palmitic acid in ischemic and reperfused canine myocardiumJournal of the American College of Cardiology, 1985
- C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. IV. In vivo evaluation of acute demand-induced ischemia in dogsAmerican Heart Journal, 1983
- Preparation of [1−11C]acetate—An agent for the study of myocardial metabolism by positron emission tomographyThe International Journal of Applied Radiation and Isotopes, 1982
- C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography: II. Kinetics of C-11 palmitic acid in acutely ischemimic myocardiumAmerican Heart Journal, 1982
- C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomographyAmerican Heart Journal, 1982
- A critical look at currently used indirect indices of myocardial oxygen consumptionBasic Research in Cardiology, 1981
- Alterations of carbohydrate and lipid metabolism in the acutely ischemic heartProgress in Cardiovascular Diseases, 1981
- Quantitation in Positron Emission Computed TomographyJournal of Computer Assisted Tomography, 1979
- Indirect assessment of myocardial oxygen consumption in the evaluation of mechanisms and therapy of angina pectorisThe American Journal of Cardiology, 1974